Sidra Azim, MD
Endocrinology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Azim’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$270,726
Medicare paid this office $270,726 for 435 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, denosumab, 1 mg | 60 | $123,168 | None |
| Return visit (30+ min) | 272 | $48,469 | $113 |
| New patient visit (45+ min) | 104 | $15,235 | $146 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 64 | $8,818 | $130 |
| Short return visit (20+ min) | 48 | $3,912 | $80 |
See all 9 services
| Injection, denosumab, 1 mg | 60 | $123,168 | None |
| Return visit (30+ min) | 272 | $48,469 | $113 |
| New patient visit (45+ min) | 104 | $15,235 | $146 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 64 | $8,818 | $130 |
| Short return visit (20+ min) | 48 | $3,912 | $80 |
| Injection of drug or substance under skin or into muscle | 66 | $2,649 | $14 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 32 | $1,922 | $30 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 15 | $1,070 | $56 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 35 | $493 | $14 |
Who their Medicare patients are
435 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 17% · Women 72% · Also on Medicaid 13% · Health risk score 1.12. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 67% · Diabetes 36% · Chronic kidney disease 31% · Coronary heart disease 20% · Cancer 19% · Atrial fibrillation 17% · Depression 17% · Heart failure 14% · COPD 10% · Dementia 6% · Stroke 6%.
The office billed $784,215, Medicare allowed $349,667 and paid $270,726; for 16,579 services of 15 kinds; $186,142 of it was for drugs given in the office and $84,584 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 435 | 16,579 | 76 | 1.12 | $784,215 | $270,726 |
| 2023 | 429 | 14,327 | 75 | 1.15 | $655,717 | $216,174 |
| 2022 | 395 | 14,105 | 76 | 1.03 | $670,023 | $221,189 |
| 2021 | 336 | 7,270 | 75 | 1.08 | $473,019 | $164,313 |
| 2020 | 303 | 2,014 | 71 | 1.93 | $175,327 | $64,902 |
| 2019 | 397 | 2,717 | 68 | 2.58 | $218,532 | $98,432 |
| 2018 | 479 | 2,337 | 69 | 2.55 | $225,827 | $103,130 |
| 2017 | 185 | 413 | 68 | 2.76 | $78,174 | $34,790 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Injection, denosumab, 1 mg | 47 | $81,890 | None |
| Return visit (30+ min) | 244 | $46,603 | $112 |
| New patient visit (45+ min) | 110 | $15,936 | $145 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 69 | $10,269 | $135 |
| Short return visit (20+ min) | 95 | $8,455 | $81 |
| Injection of drug or substance under skin or into muscle | 51 | $2,072 | $14 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 23 | $1,551 | $52 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 20 | $1,508 | $30 |
2022: 9 services
| Injection, denosumab, 1 mg | 47 | $85,840 | None |
| Return visit (30+ min) | 254 | $53,295 | $112 |
| New patient visit (45+ min) | 114 | $16,361 | $144 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 62 | $10,218 | $138 |
| Short return visit (20+ min) | 37 | $3,035 | $80 |
| Long return visit (40+ min) | 15 | $2,739 | $171 |
| Injection of drug or substance under skin or into muscle | 50 | $1,953 | $14 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 25 | $1,621 | $31 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 14 | $979 | $58 |
2021: 11 services
| Injection, denosumab, 1 mg | 42 | $74,143 | None |
| Return visit (30+ min) | 205 | $40,461 | $120 |
| New patient visit (45+ min) | 73 | $11,873 | $163 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 47 | $7,360 | $139 |
| New patient visit (60+ min) | 42 | $7,301 | $174 |
| Long return visit (40+ min) | 46 | $7,148 | $140 |
| Short return visit (20+ min) | 41 | $3,902 | $87 |
| Injection of drug or substance under skin or into muscle | 45 | $1,255 | $14 |
| New patient visit (30+ min) | 11 | $1,219 | $111 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 19 | $997 | $32 |
| Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 14 | $937 | $55 |
2020: 13 services
| Injection, denosumab, 1 mg | 22 | $20,850 | None |
| Return visit (30+ min) | 138 | $11,847 | $76 |
| Long return visit (40+ min) | 47 | $6,461 | $132 |
| New patient visit (60+ min) | 26 | $4,764 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $3,299 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,221 | $115 |
| New patient visit (45+ min) | 21 | $2,758 | $131 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,501 | $94 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $1,331 | $58 |
| Short return visit (20+ min) | 19 | $1,052 | $55 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 11 | $412 | $32 |
| Injection of drug or substance under skin or into muscle | 25 | $345 | $13 |
| Hemoglobin a1c level, by device for home use | 11 | $105 | $10 |
2019: 12 services
| Return visit (30+ min) | 201 | $28,428 | $83 |
| Injection, denosumab, 1 mg | 17 | $24,910 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 127 | $20,706 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 89 | $11,315 | $113 |
| New patient visit (45+ min) | 35 | $4,905 | $140 |
| Short return visit (20+ min) | 34 | $1,989 | $49 |
| Ultrasound scan of head and neck soft tissue | 19 | $1,523 | $80 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 25 | $862 | $32 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 18 | $662 | $30 |
| Hemoglobin a1c level, by device for home use | 33 | $455 | $11 |
| Injection of drug or substance under skin or into muscle | 18 | $403 | $14 |
| Insertion of needle into vein for collection of blood sample | 13 | $38 | $3 |
2018: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 165 | $25,984 | $61 |
| Return visit (30+ min) | 193 | $23,983 | $85 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 163 | $19,999 | $116 |
| Injection, denosumab, 1 mg | 18 | $17,212 | None |
| New patient visit (45+ min) | 37 | $4,987 | $135 |
| Short return visit (20+ min) | 56 | $3,729 | $58 |
| Ultrasound scan of head and neck soft tissue | 18 | $1,853 | $98 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $729 | $33 |
| Hemoglobin a1c level, by device for home use | 35 | $519 | $11 |
| Injection of drug or substance under skin or into muscle | 18 | $356 | $18 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 92 | $11,058 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 77 | $9,007 | $115 |
| New patient visit (45+ min) | 49 | $6,749 | $138 |
| Return visit (30+ min) | 33 | $4,100 | $89 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $397 | $33 |
Medicaid work
$652 in 2023
Medicaid paid $652 for 26 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 26 | $652 |
| 2023 | 26 | 1 | 13 | $652 |
| 2022 | 13 | 1 | 13 | $124 |
| 2021 | 13 | 1 | 13 | $335 |
| 2020 | 80 | 1 | 28 | $2,856 |
| 2019 | 637 | 3 | 31 | $16,064 |
| 2018 | 1,330 | 3 | 42 | $21,735 |
See the largest Medicaid services in earlier years
2022
| Return visit (30+ min) | 13 | $124 |
2021
| Return visit (30+ min) | 13 | $335 |
2020
| Return visit (30+ min) | 80 | $2,856 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 356 | $7,454 |
| Return visit (30+ min) | 221 | $6,343 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 60 | $2,267 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 888 | $12,085 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 256 | $6,750 |
| Return visit (30+ min) | 186 | $2,900 |
Drugs they prescribed that Part D paid
$977,673
Pharmacies billed $977,673 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,073) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
1,017 generic and 966 brand-name prescriptions · $977,673 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trulicity | 140 | $231,214 | $1,652 |
| Ozempic | 104 | $169,656 | $1,631 |
| Jardiance | 98 | $141,498 | $1,444 |
| Mounjaro | 46 | $72,812 | $1,583 |
| Rybelsus | 20 | $51,510 | $2,576 |
See all 37 drugs
| Trulicity | 140 | $231,214 | $1,652 |
| Ozempic | 104 | $169,656 | $1,631 |
| Jardiance | 98 | $141,498 | $1,444 |
| Mounjaro | 46 | $72,812 | $1,583 |
| Rybelsus | 20 | $51,510 | $2,576 |
| Januvia | 18 | $26,912 | $1,495 |
| Farxiga | 15 | $20,354 | $1,357 |
| Tresiba Flextouch U-100 | 23 | $15,675 | $682 |
| Lantus Solostar | 56 | $10,519 | $188 |
| Humalog Kwikpen U-100 | 19 | $9,943 | $523 |
| Synthroid | 64 | $7,932 | $124 |
| Novolog Flexpen | 17 | $6,368 | $375 |
| Nano 2nd Gen Pen Needle | 36 | $5,145 | $143 |
| Cinacalcet | 14 | $4,593 | $328 |
| Insulin Lispro Kwikpen U-100 | 11 | $3,501 | $318 |
| Levothyroxine | 244 | $3,288 | $13 |
| Humalog | 19 | $3,273 | $172 |
| Ultra-Fine Mini Pen Needle | 22 | $2,903 | $132 |
| Insulin Aspart Flexpen | 12 | $2,541 | $212 |
| Hydrocortisone | 60 | $2,196 | $37 |
| Levoxyl | 53 | $2,064 | $39 |
| Humulin N | 14 | $1,615 | $115 |
| Liothyronine | 33 | $1,260 | $38 |
| Metformin Hcl Er | 94 | $1,253 | $13 |
| Testosterone | 11 | $1,236 | $112 |
| Metformin | 89 | $937 | $11 |
| Glipizide | 59 | $924 | $16 |
| Alendronate | 85 | $851 | $10 |
| Methimazole | 64 | $774 | $12 |
| Rosuvastatin | 30 | $552 | $18 |
| Pioglitazone | 31 | $536 | $17 |
| Glimepiride | 43 | $512 | $12 |
| Glipizide Er | 30 | $497 | $17 |
| Calcitriol | 18 | $443 | $25 |
| Atorvastatin | 37 | $329 | $9 |
| Losartan | 16 | $158 | $10 |
| Dexamethasone | 14 | $15 | $1 |
Year by year
| 2024 | 2,073 | 309 | 0% (0) | 47% | $977,673 |
| 2023 | 1,851 | 297 | 0% (0) | 46% | $926,591 |
| 2022 | 1,579 | 275 | 0% (0) | 45% | $736,621 |
| 2021 | 1,199 | 310 | 0% (0) | 49% | $607,085 |
| 2020 | 2,466 | 418 | 0% (0) | 53% | $1,470,441 |
| 2019 | 2,699 | 404 | 0% (0) | 47% | $1,491,336 |
| 2018 | 1,627 | 347 | 0% (0) | 46% | $688,188 |
| 2017 | 521 | 88 | 0% (0) | 44% | $147,324 |
| 2016 | 250 | 49 | 0% (0) | 39% | $48,750 |
| 2015 | 84 | 32 | 0% (0) | None | $14,608 |
| 2014 | 776 | 79 | None | 25% | $43,182 |
| 2013 | 916 | 130 | 2% (14) | 19% | $36,673 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 32 drugs
| Trulicity | 168 | $271,590 | $1,617 |
| Jardiance | 68 | $96,322 | $1,417 |
| Ozempic | 40 | $74,610 | $1,865 |
| Rybelsus | 28 | $57,385 | $2,049 |
| Lantus Solostar | 59 | $41,813 | $709 |
| Mounjaro | 29 | $39,249 | $1,353 |
| Tymlos | 12 | $31,248 | $2,604 |
| Novolog Flexpen | 33 | $30,484 | $924 |
| Humalog Kwikpen U-100 | 13 | $23,467 | $1,805 |
| Januvia | 16 | $23,216 | $1,451 |
| Farxiga | 11 | $16,892 | $1,536 |
| Tresiba Flextouch U-100 | 16 | $12,028 | $752 |
| Synthroid | 65 | $8,114 | $125 |
| Nano 2nd Gen Pen Needle | 38 | $4,604 | $121 |
| Levothyroxine | 239 | $4,181 | $17 |
| Hydrocortisone | 53 | $3,195 | $60 |
| Ultra-Fine Mini Pen Needle | 16 | $2,254 | $141 |
| Levoxyl | 60 | $1,587 | $26 |
| Metformin Hcl Er | 71 | $1,526 | $21 |
| Glipizide | 66 | $1,286 | $19 |
| Alendronate | 89 | $1,130 | $13 |
| Methimazole | 78 | $1,057 | $14 |
| Glipizide Er | 32 | $1,047 | $33 |
| Metformin | 75 | $1,037 | $14 |
| Pioglitazone | 25 | $815 | $33 |
| Ultra-Fine Nano Pen Needle | 13 | $781 | $60 |
| Calcitriol | 19 | $741 | $39 |
| Atorvastatin | 23 | $506 | $22 |
| Liothyronine | 24 | $377 | $16 |
| Glimepiride | 34 | $224 | $7 |
| Rosuvastatin | 22 | $196 | $9 |
| Simvastatin | 11 | $63 | $6 |
2022: 34 drugs
| Trulicity | 104 | $188,284 | $1,810 |
| Jardiance | 44 | $70,141 | $1,594 |
| Rybelsus | 28 | $54,020 | $1,929 |
| Forteo | 11 | $46,702 | $4,246 |
| Lantus Solostar | 56 | $42,931 | $767 |
| Ozempic | 25 | $41,131 | $1,645 |
| Januvia | 31 | $28,236 | $911 |
| Tymlos | 12 | $27,071 | $2,256 |
| Lantus | 15 | $18,718 | $1,248 |
| Humalog | 14 | $17,096 | $1,221 |
| Novolog Flexpen | 18 | $16,361 | $909 |
| Testosterone | 11 | $6,714 | $610 |
| Synthroid | 59 | $6,419 | $109 |
| Basaglar Kwikpen U-100 | 15 | $5,788 | $386 |
| Levothyroxine | 202 | $3,460 | $17 |
| Hydrocortisone | 41 | $2,401 | $59 |
| Ultra-Fine Mini Pen Needle | 19 | $2,163 | $114 |
| Levoxyl | 54 | $1,635 | $30 |
| Nano 2nd Gen Pen Needle | 17 | $1,479 | $87 |
| Metformin Hcl Er | 80 | $1,172 | $15 |
| Calcitriol | 11 | $748 | $68 |
| Methimazole | 69 | $708 | $10 |
| Alendronate | 85 | $691 | $8 |
| Metformin | 59 | $660 | $11 |
| Glipizide | 53 | $593 | $11 |
| Glipizide Er | 20 | $531 | $27 |
| Ultra-Fine Nano Pen Needle | 11 | $509 | $46 |
| Liothyronine | 20 | $491 | $25 |
| Rosuvastatin | 12 | $356 | $30 |
| Atorvastatin | 30 | $336 | $11 |
| Pioglitazone | 18 | $286 | $16 |
| Glimepiride | 35 | $268 | $8 |
| Amlodipine Besylate | 17 | $125 | $7 |
| Losartan | 12 | $92 | $8 |
2021: 31 drugs
| Trulicity | 72 | $123,709 | $1,718 |
| Ozempic | 44 | $65,269 | $1,483 |
| Forteo | 11 | $48,389 | $4,399 |
| Jardiance | 26 | $44,084 | $1,696 |
| Novolog Flexpen | 26 | $36,701 | $1,412 |
| Januvia | 37 | $34,340 | $928 |
| Rybelsus | 15 | $26,539 | $1,769 |
| Lantus Solostar | 42 | $18,287 | $435 |
| Tresiba Flextouch U-200 | 12 | $17,215 | $1,435 |
| Humalog Kwikpen U-100 | 18 | $9,314 | $517 |
| Humalog | 12 | $8,989 | $749 |
| Basaglar Kwikpen U-100 | 21 | $8,194 | $390 |
| Tresiba Flextouch U-100 | 12 | $7,059 | $588 |
| Testosterone | 17 | $6,990 | $411 |
| Insulin Lispro Kwikpen U-100 | 14 | $6,430 | $459 |
| Synthroid | 31 | $3,969 | $128 |
| Levothyroxine | 118 | $2,589 | $22 |
| Ultra-Fine Mini Pen Needle | 21 | $2,505 | $119 |
| Nano 2nd Gen Pen Needle | 13 | $1,580 | $122 |
| Hydrocortisone | 24 | $1,292 | $54 |
| Levoxyl | 32 | $1,206 | $38 |
| Methimazole | 49 | $1,013 | $21 |
| Calcitriol | 12 | $803 | $67 |
| Metformin Hcl Er | 52 | $651 | $13 |
| Metformin | 44 | $458 | $10 |
| Glipizide Er | 12 | $387 | $32 |
| Glimepiride | 30 | $366 | $12 |
| Glipizide | 43 | $343 | $8 |
| Pioglitazone | 25 | $334 | $13 |
| Alendronate | 49 | $321 | $7 |
| Atorvastatin | 19 | $179 | $9 |
2020: 44 drugs
| Ozempic | 110 | $198,598 | $1,805 |
| Trulicity | 90 | $163,722 | $1,819 |
| Jardiance | 98 | $134,139 | $1,369 |
| Forteo | 11 | $95,342 | $8,667 |
| Humalog Kwikpen U-100 | 74 | $88,292 | $1,193 |
| Januvia | 76 | $85,738 | $1,128 |
| Victoza 3-Pak | 33 | $75,444 | $2,286 |
| Lantus Solostar | 109 | $66,147 | $607 |
| Novolog Flexpen | 42 | $46,779 | $1,114 |
| Tresiba Flextouch U-200 | 38 | $43,510 | $1,145 |
| Tresiba Flextouch U-100 | 45 | $35,989 | $800 |
| Janumet Xr | 30 | $30,057 | $1,002 |
| Humalog Kwikpen U-200 | 13 | $29,737 | $2,287 |
| Novolog | 30 | $27,855 | $928 |
| Cinacalcet | 13 | $22,089 | $1,699 |
| Toujeo Solostar | 20 | $17,070 | $854 |
| Basaglar Kwikpen U-100 | 40 | $16,104 | $403 |
| Levemir Flextouch | 22 | $15,948 | $725 |
| Farxiga | 11 | $15,708 | $1,428 |
| Humalog | 15 | $15,539 | $1,036 |
| Invokana | 12 | $12,726 | $1,060 |
| Tradjenta | 25 | $11,812 | $472 |
| Insulin Lispro Kwikpen U-100 | 25 | $11,123 | $445 |
| Synthroid | 100 | $10,504 | $105 |
| Ultra-Fine Nano Pen Needle | 64 | $7,208 | $113 |
| Levothyroxine | 235 | $6,544 | $28 |
| Vascepa | 13 | $6,492 | $499 |
| Liothyronine | 41 | $3,519 | $86 |
| Pregabalin | 19 | $1,841 | $97 |
| Metformin | 143 | $1,531 | $11 |
| Nateglinide | 19 | $1,416 | $75 |
| Rosuvastatin | 44 | $1,347 | $31 |
| Ultra-Fine Mini Pen Needle | 12 | $1,251 | $104 |
| Methimazole | 43 | $1,126 | $26 |
| Atorvastatin | 71 | $1,082 | $15 |
| Metformin Hcl Er | 77 | $1,073 | $14 |
| Alendronate | 71 | $952 | $13 |
| Glimepiride | 54 | $844 | $16 |
| Pioglitazone | 36 | $613 | $17 |
| Hydrocortisone | 11 | $450 | $41 |
| Unithroid | 12 | $377 | $31 |
| Gabapentin | 19 | $211 | $11 |
| Glipizide | 28 | $197 | $7 |
| Lisinopril | 19 | $138 | $7 |
2019: 50 drugs
| Trulicity | 105 | $179,520 | $1,710 |
| Humalog Kwikpen U-100 | 96 | $122,076 | $1,272 |
| Forteo | 23 | $109,731 | $4,771 |
| Ozempic | 51 | $89,596 | $1,757 |
| Jardiance | 63 | $80,930 | $1,285 |
| Metformin Er Gastric | 17 | $74,632 | $4,390 |
| Januvia | 79 | $73,038 | $925 |
| Victoza 3-Pak | 38 | $71,594 | $1,884 |
| Lantus Solostar | 109 | $69,295 | $636 |
| Novolog Flexpen | 34 | $31,969 | $940 |
| Tresiba Flextouch U-100 | 37 | $30,096 | $813 |
| Humalog | 19 | $27,983 | $1,473 |
| Novolog | 23 | $27,381 | $1,190 |
| Humulin R U-500 | 12 | $26,559 | $2,213 |
| Toujeo Solostar | 26 | $26,124 | $1,005 |
| Levemir Flextouch | 26 | $25,739 | $990 |
| Tresiba Flextouch U-200 | 26 | $24,687 | $949 |
| Janumet Xr | 22 | $23,875 | $1,085 |
| Tradjenta | 24 | $18,093 | $754 |
| Lantus | 20 | $14,421 | $721 |
| Bydureon Bcise | 15 | $12,015 | $801 |
| Cinacalcet | 12 | $11,230 | $936 |
| Synthroid | 121 | $10,957 | $91 |
| Sensipar | 12 | $9,886 | $824 |
| Basaglar Kwikpen U-100 | 11 | $9,373 | $852 |
| Ultra-Fine Nano Pen Needle | 86 | $8,753 | $102 |
| Invokana | 13 | $7,856 | $604 |
| Levothyroxine | 290 | $7,372 | $25 |
| Liothyronine | 72 | $5,212 | $72 |
| V-Go 40 | 12 | $4,448 | $371 |
| Rosuvastatin | 82 | $4,157 | $51 |
| Nateglinide | 21 | $2,510 | $120 |
| Metformin Hcl Er | 106 | $2,066 | $19 |
| Ultra-Fine Short Pen Needle | 17 | $1,775 | $104 |
| Armour Thyroid | 15 | $1,321 | $88 |
| Metformin | 122 | $1,264 | $10 |
| Atorvastatin | 91 | $1,236 | $14 |
| Ultra-Fine Mini Pen Needle | 14 | $1,161 | $83 |
| Methimazole | 57 | $1,108 | $19 |
| Glimepiride | 53 | $1,071 | $20 |
| Alendronate | 100 | $1,045 | $10 |
| Gabapentin | 23 | $610 | $27 |
| Pioglitazone | 16 | $525 | $33 |
| Unithroid | 19 | $488 | $26 |
| Glipizide | 29 | $346 | $12 |
| Lisinopril | 47 | $282 | $6 |
| Losartan | 25 | $258 | $10 |
| Estradiol | 11 | $104 | $9 |
| Medroxyprogesterone Acetate | 13 | $99 | $8 |
| Hydrochlorothiazide | 14 | $83 | $6 |
2018: 38 drugs
| Victoza 3-Pak | 63 | $96,334 | $1,529 |
| Forteo | 21 | $85,312 | $4,062 |
| Trulicity | 50 | $68,303 | $1,366 |
| Humalog Kwikpen U-100 | 45 | $50,898 | $1,131 |
| Januvia | 51 | $46,073 | $903 |
| Lantus Solostar | 65 | $42,114 | $648 |
| Novolog Flexpen | 23 | $26,303 | $1,144 |
| Levemir Flextouch | 26 | $20,764 | $799 |
| Novolog | 19 | $17,991 | $947 |
| Tresiba Flextouch U-200 | 13 | $13,731 | $1,056 |
| Humalog | 11 | $12,977 | $1,180 |
| Jardiance | 11 | $11,138 | $1,013 |
| Tradjenta | 21 | $10,606 | $505 |
| Lantus | 11 | $10,424 | $948 |
| Invokana | 11 | $10,086 | $917 |
| Janumet Xr | 16 | $9,982 | $624 |
| Lyrica | 12 | $7,500 | $625 |
| Synthroid | 57 | $5,018 | $88 |
| Ultra-Fine Nano Pen Needle | 49 | $3,635 | $74 |
| Levothyroxine | 190 | $3,611 | $19 |
| Nateglinide | 31 | $2,746 | $89 |
| Ultra-Fine Short Pen Needle | 18 | $2,452 | $136 |
| Liothyronine | 34 | $1,483 | $44 |
| Metformin Hcl Er | 67 | $1,355 | $20 |
| Rosuvastatin | 25 | $1,343 | $54 |
| Ibandronate | 14 | $1,008 | $72 |
| Metformin | 65 | $869 | $13 |
| Atorvastatin | 57 | $818 | $14 |
| Glimepiride | 26 | $700 | $27 |
| Fenofibrate | 11 | $583 | $53 |
| Methimazole | 26 | $466 | $18 |
| Alendronate | 36 | $385 | $11 |
| Glipizide | 35 | $381 | $11 |
| Losartan | 24 | $284 | $12 |
| Prednisone | 22 | $258 | $12 |
| Lisinopril | 39 | $196 | $5 |
| Gabapentin | 11 | $153 | $14 |
| Dexamethasone | 13 | $23 | $2 |
2017: 15 drugs
| Lantus Solostar | 37 | $26,872 | $726 |
| Victoza 3-Pak | 20 | $21,883 | $1,094 |
| Novolog Flexpen | 12 | $15,691 | $1,308 |
| Trulicity | 13 | $13,309 | $1,024 |
| Januvia | 16 | $10,806 | $675 |
| Janumet | 20 | $8,642 | $432 |
| Humalog Kwikpen U-100 | 11 | $7,272 | $661 |
| Ultra-Fine Nano Pen Needle | 27 | $1,704 | $63 |
| Levothyroxine | 57 | $1,042 | $18 |
| Metformin Hcl Er | 30 | $348 | $12 |
| Atorvastatin | 29 | $332 | $11 |
| Hydrocortisone | 11 | $277 | $25 |
| Metformin | 25 | $203 | $8 |
| Glipizide Er | 13 | $196 | $15 |
| Lisinopril | 22 | $68 | $3 |
2016: 6 drugs
| Januvia | 14 | $8,815 | $630 |
| Lantus Solostar | 20 | $7,799 | $390 |
| Humalog Kwikpen U-100 | 13 | $6,165 | $474 |
| Levothyroxine | 37 | $662 | $18 |
| Atorvastatin | 13 | $211 | $16 |
| Metformin Hcl Er | 11 | $99 | $9 |
2014: 23 drugs
| Advair Diskus | 25 | $9,413 | $377 |
| Lyrica | 11 | $3,696 | $336 |
| Nexium | 14 | $3,425 | $245 |
| Spiriva | 11 | $3,190 | $290 |
| Proair Hfa | 16 | $793 | $50 |
| Atorvastatin | 70 | $780 | $11 |
| Ventolin Hfa | 11 | $499 | $45 |
| Omeprazole | 19 | $226 | $12 |
| Gabapentin | 23 | $212 | $9 |
| Lisinopril | 49 | $204 | $4 |
| Pantoprazole | 26 | $199 | $8 |
| Amlodipine Besylate | 45 | $194 | $4 |
| Levothyroxine | 16 | $193 | $12 |
| Enalapril Maleate | 13 | $165 | $13 |
| Triamcinolone Acetonide | 13 | $148 | $11 |
| Metformin | 14 | $121 | $9 |
| Hydrochlorothiazide | 36 | $121 | $3 |
| Simvastatin | 16 | $121 | $8 |
| Carvedilol | 21 | $118 | $6 |
| Finasteride | 16 | $111 | $7 |
| Metformin Hcl Er | 13 | $80 | $6 |
| Metoprolol | 17 | $76 | $4 |
| Furosemide | 14 | $72 | $5 |
2013: 18 drugs
| Lantus | 11 | $1,768 | $161 |
| Atorvastatin | 60 | $1,067 | $18 |
| Gabapentin | 34 | $647 | $19 |
| Omeprazole | 51 | $620 | $12 |
| Labetalol | 14 | $502 | $36 |
| Amlodipine Besylate | 77 | $431 | $6 |
| Hydrochlorothiazide | 47 | $350 | $7 |
| Lisinopril | 56 | $304 | $5 |
| Enalapril Maleate | 20 | $286 | $14 |
| Carvedilol | 27 | $218 | $8 |
| Metformin | 21 | $192 | $9 |
| Simvastatin | 28 | $179 | $6 |
| Pantoprazole | 21 | $173 | $8 |
| Levothyroxine | 22 | $170 | $8 |
| Alendronate | 11 | $97 | $9 |
| Benazepril | 12 | $68 | $6 |
| Furosemide | 13 | $58 | $4 |
| Metoprolol | 11 | $54 | $5 |
Money from drug and device companies
$122 in 2025
| 2025 | 1 | 1 | None | $122 |
| 2024 | 2 | 2 | None | $286 |
| 2022 | 1 | 1 | None | $12 |
| 2021 | 1 | 1 | None | $14 |
| 2020 | 13 | 20 | None | $391 |
| 2019 | 18 | 69 | $600 | $1,829 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ascendis Pharma Endocrinology | Yorvipath | $122 | 1 payment
|
See the published payment
| Ascendis Pharma Endocrinology | Meals · 2025-04-05 | Yorvipath | $122 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $286
| Beta Bionics | Ilet Bionic Pancreas | $164 | 1 payment
|
| Sanofi-Aventis U.S. | Tzield | $122 | 1 payment
|
2022: $12
| Lilly USA | None | $12 | 1 payment
|
2021: $14
| GlaxoSmithKline | Trelegy Ellipta | $14 | 1 payment
|
2020: $391
| Abbott Laboratories | Freestyle Libre | $83 | 4 payments
|
| Amgen | Evenity | $68 | 3 payments
|
| Dexcom | Dexcom G6 Cgm System | $59 | 3 payments
|
| Corcept Therapeutics | Korlym | $26 | 1 payment
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $21 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | None | $21 | 1 payment
|
| Endo Pharmaceuticals | Aveed | $19 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $17 | 1 payment
|
| Amarin Pharma | Vascepa | $15 | 1 payment
|
| AbbVie | None | $15 | 1 payment
|
| Novo Nordisk | Ozempic | $13 | 1 payment
|
| Lilly USA | Baqsimi | $13 | 1 payment
|
2019: $1,829
| Tandem Diabetes Care | T-Slim Insulin Pump | $706 | 9 payments
|
| Amgen | Evenity | $268 | 9 payments
|
| Dexcom | Dexcom Cgm | $182 | 8 payments
|
| Novo Nordisk | Ozempic | $168 | 12 payments
|
| Abbott Laboratories | Freestyle Libre | $109 | 9 payments
|
| Lilly USA | Basaglar | $56 | 3 payments
|
| Medtronic MiniMed | Guardian Connect | $44 | 2 payments
|
| AbbVie | Synthroid | $44 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $42 | 2 payments
|
| IBSA Pharma | Tirosint | $40 | 2 payments
|
| Insulet | Omnipod | $40 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $29 | 2 payments
|
| Becton Dickinson and | Bd Nano | $21 | 1 payment
|
| Sanofi-Aventis U.S. | Toujeo | $21 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $16 | 1 payment
|
| Amarin Pharma | Vascepa | $16 | 1 payment
|
| Shire North American Group | Natpara (Parathyroid Hormone) | $16 | 1 payment
|
| Aytu BioScience | Natesto | $13 | 1 payment
|
Professional record
- NPI
- 1043598378
- Licence
- CT 55691
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2011-08-03
- NPI last updated
- 2020-09-28
- NPI record certified
- 2020-09-28
This is when the NPI record was last certified, not a medical board exam.